Home » Topics » BioWorld Science

BioWorld Science
RSS

Cabaletta Bio and Artisan Bio collaborate to develop next-generation CAAR T-cell therapies

July 8, 2020

Novel innovative COVID-19 drug testing platform launched in the U.K.

July 8, 2020

Enrollment completed in pivotal DERBY and OAKS studies of pegcetacoplan

July 8, 2020

ImmuneOnco Biopharmaceuticals divulges anti-PD-L1 and anti-VEGF compounds

July 8, 2020

RemeGen describes new angiogenesis inhibitors

July 8, 2020

Prelude Therapeutics discloses Mcl-1 inhibitors

July 8, 2020

Theravance Biopharma patents TGFR-1 inhibitors

July 8, 2020

Dana-Farber Cancer Institute presents new MAPK9 inhibitors

July 8, 2020

ImmunoGen presents next-generation FR-alpha-targeting ADC, IMGN-151

July 8, 2020

Discovery of novel HDAC6 selective inhibitors with potent preclinical activity

July 8, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...